RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Cancer, Cardiology, Hematology |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Hematology, Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/21/2016 |
| Start Date: | March 2012 |
| End Date: | December 2025 |
Multi-Institution Registry of SRS/SBRT Procedures
The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT
(Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment
practices and outcomes to help determine, over time, the most effective use of these systems
in management of patients with life threatening tumors and other diseases. (This study was
formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a
CyberKnife subset of RSSearch.)
(Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment
practices and outcomes to help determine, over time, the most effective use of these systems
in management of patients with life threatening tumors and other diseases. (This study was
formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a
CyberKnife subset of RSSearch.)
The Registry is designed to help SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body
Radiation Therapy) users to understand utilization of and key treatment outcomes for these
treatment approaches. Some of the objectives include:
Allow participants to record information about usage of SRS/SBRT in everyday practice,
including patient characteristics and disease information, treatment plans and outcomes
Provide participants with ready access to data for publication of their own experience and
as a tool for establishing collaborations with other participating sites Facilitate quality
improvement efforts for individual treatment providers Understand the effectiveness of
different treatment plans for different types of lesions, diseases and treatments
The Registry tracks select outcomes for each condition treated by SRS/SBRT (for example, PSA
for prostate cancer); the Registry also provides individual participants the ability to add
additional outcomes for each and any condition of specific interest to their institutions.
The Registry is hosted by Advertek, Inc who is an independent vendor of electronic
registries; they are responsible for HIPAA compliance, including all security mechanisms.
Patients will be enrolled prospectively. Some retrospective patient data is likely to be
included in order to capture both short and longer term outcomes data.
Radiation Therapy) users to understand utilization of and key treatment outcomes for these
treatment approaches. Some of the objectives include:
Allow participants to record information about usage of SRS/SBRT in everyday practice,
including patient characteristics and disease information, treatment plans and outcomes
Provide participants with ready access to data for publication of their own experience and
as a tool for establishing collaborations with other participating sites Facilitate quality
improvement efforts for individual treatment providers Understand the effectiveness of
different treatment plans for different types of lesions, diseases and treatments
The Registry tracks select outcomes for each condition treated by SRS/SBRT (for example, PSA
for prostate cancer); the Registry also provides individual participants the ability to add
additional outcomes for each and any condition of specific interest to their institutions.
The Registry is hosted by Advertek, Inc who is an independent vendor of electronic
registries; they are responsible for HIPAA compliance, including all security mechanisms.
Patients will be enrolled prospectively. Some retrospective patient data is likely to be
included in order to capture both short and longer term outcomes data.
Inclusion Criteria:
- Diagnosis of benign or malignant tumors or other conditions deemed treatable by
stereotactic radiosurgery or stereotactic body radiotherapy
- Willingness to sign an Informed Consent Document
Exclusion Criteria:
- There are no specific exclusion criteria, but patients who are unwilling to sign the
ICD will not be included
We found this trial at
0
sites